- Investing Ideas
- Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
19
High return on equity, past performance and sound balance sheet.
19 companies
Sanofi Consumer Healthcare India
Market Cap: ₹108.7b
Operates as a fast-moving consumer healthcare company in India.
SANOFICONR
₹4,720.00
7D
2.2%
1Y
-4.4%
ALTEOGEN
Market Cap: ₩19.6t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩366,000.00
7D
1.2%
1Y
-6.9%
Sanofi India
Market Cap: ₹82.0b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,559.80
7D
1.9%
1Y
-42.8%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹415.3b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,451.80
7D
2.4%
1Y
-15.7%
Abbott India
Market Cap: ₹548.2b
Operates as a pharmaceutical company in India.
500488
₹25,797.15
7D
0.1%
1Y
-15.9%
Pharma Mar
Market Cap: €1.7b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€97.35
7D
4.8%
1Y
29.9%
Highnoon Laboratories
Market Cap: PK₨54.9b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,036.72
7D
3.9%
1Y
10.3%
GlaxoSmithKline Pakistan
Market Cap: PK₨125.3b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨393.49
7D
6.9%
1Y
-10.6%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س10.9b
Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.
4015
ر.س155.70
7D
1.8%
1Y
1.6%
China Resources Jiangzhong PharmaceuticalLtd
Market Cap: CN¥17.0b
Engages in the manufacture of pharmaceutical products in China.
600750
CN¥26.96
7D
3.9%
1Y
16.7%
Middle East Pharmaceutical Industries
Market Cap: ر.س2.2b
Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.
4016
ر.س107.90
7D
5.3%
1Y
-16.7%
Exelixis
Market Cap: US$11.5b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$44.89
7D
1.4%
1Y
24.0%
Consun Pharmaceutical Group
Market Cap: HK$13.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.31
7D
-4.2%
1Y
72.4%
DHG Pharmaceutical
Market Cap: ₫13.0t
Engages in the manufacture and sale of pharmaceutical products in Vietnam.
DHG
₫99,700.00
7D
-0.7%
1Y
3.4%
Rigel Pharmaceuticals
Market Cap: US$586.9m
A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
RIGL
US$32.43
7D
11.1%
1Y
92.5%
Chugai Pharmaceutical
Market Cap: JP¥13.7t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,349.00
7D
-3.8%
1Y
0.3%
Gubra
Market Cap: DKK 5.7b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 357.00
7D
4.8%
1Y
0.3%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥7.3b
Engages in the pharmaceutical business in China.
000915
CN¥31.35
7D
-0.8%
1Y
5.4%
Blue Jet Healthcare
Market Cap: ₹73.3b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹422.65
7D
3.9%
1Y
-44.5%